ARCHIVES

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Series Helps Do In Woodward As Post Metro Editor; OCC RFP Canceled, to Reappear As 4-5 RFPs

January 15, 1982

Spending Measures Include Provisions On Ethics For NIH Extramural Scientists.

July 11, 2008

NCI Funding Notice.

July 4, 2003

Morale, Money Woes Hit MD Anderson

January 18, 2013

Text of concept statement included in this 8-page issue.

July 16, 2004

In Brief: William Longmire Replaces Fisher On Cancer Panel; Talbot Urges Organizations To Avoid Polarization

July 9, 1982